MAP2K5 and small cell lung carcinoma: Additionally, Cristea’s research revealed that MEK5-ERK5 participated in lipid metabolism in small-cell lung cancer through the cholesterol synthesis pathway by regulating sterol regulatory element binding protein (SREBP) (Cristea et al., 2020).